Literature DB >> 17492906

Host genetics of mycobacterial diseases in mice and men: forward genetic studies of BCG-osis and tuberculosis.

A Fortin1, L Abel, J L Casanova, P Gros.   

Abstract

In humans, genetic factors have long been suspected to contribute to the onset and outcome of tuberculosis. Such effects are difficult to identify owing to their complex inheritance, and to the confounding impact of environmental factors, notably pathogen-associated virulence determinants. Recently, forward genetic approaches in mouse models and in human populations have been used to elucidate a molecular basis for predisposition to mycobacterial diseases. The genetic dissection of host predisposition to infection with Mycobacterium bovis BCG and M. tuberculosis will help to define the key molecules involved in host antituberculous immunity and should provide new insights into this important infectious disease.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17492906     DOI: 10.1146/annurev.genom.8.080706.092315

Source DB:  PubMed          Journal:  Annu Rev Genomics Hum Genet        ISSN: 1527-8204            Impact factor:   8.929


  81 in total

1.  Host genotype-specific therapies can optimize the inflammatory response to mycobacterial infections.

Authors:  David M Tobin; Francisco J Roca; Sungwhan F Oh; Ross McFarland; Thad W Vickery; John P Ray; Dennis C Ko; Yuxia Zou; Nguyen D Bang; Tran T H Chau; Jay C Vary; Thomas R Hawn; Sarah J Dunstan; Jeremy J Farrar; Guy E Thwaites; Mary-Claire King; Charles N Serhan; Lalita Ramakrishnan
Journal:  Cell       Date:  2012-02-03       Impact factor: 41.582

Review 2.  Forward genetic dissection of innate response to infection in inbred mouse strains: selected success stories.

Authors:  S Gruenheid; P Gros
Journal:  Clin Exp Immunol       Date:  2010-12       Impact factor: 4.330

3.  A statistical model for genetic mapping of viral infection by integrating epidemiological behavior.

Authors:  Yao Li; Arthur Berg; Myron N Chang; Ping Du; Kwangmi Ahn; David Mauger; Duanping Liao; Rongling Wu
Journal:  Stat Appl Genet Mol Biol       Date:  2009-09-09

4.  Genetic susceptibility in sepsis: implications for the pediatric population.

Authors:  Simon Nadel
Journal:  Paediatr Drugs       Date:  2011-08-01       Impact factor: 3.022

5.  Disseminated and rapidly fatal tuberculosis in mice bearing a defective allele at IFN regulatory factor 8.

Authors:  Jean-François Marquis; Ronald LaCourse; Lynn Ryan; Robert J North; Philippe Gros
Journal:  J Immunol       Date:  2009-03-01       Impact factor: 5.422

6.  Dominant role of the sst1 locus in pathogenesis of necrotizing lung granulomas during chronic tuberculosis infection and reactivation in genetically resistant hosts.

Authors:  Alexander V Pichugin; Bo-Shiun Yan; Alex Sloutsky; Lester Kobzik; Igor Kramnik
Journal:  Am J Pathol       Date:  2009-05-14       Impact factor: 4.307

7.  Early secreted antigenic target of 6-kDa protein of Mycobacterium tuberculosis primes dendritic cells to stimulate Th17 and inhibit Th1 immune responses.

Authors:  Xisheng Wang; Peter F Barnes; Fangfang Huang; Ivana B Alvarez; Pierre F Neuenschwander; David R Sherman; Buka Samten
Journal:  J Immunol       Date:  2012-08-17       Impact factor: 5.422

Review 8.  Sexual inequality in tuberculosis.

Authors:  Olivier Neyrolles; Lluis Quintana-Murci
Journal:  PLoS Med       Date:  2009-12-22       Impact factor: 11.069

9.  Mycobacterium tuberculosis infection induces il12rb1 splicing to generate a novel IL-12Rbeta1 isoform that enhances DC migration.

Authors:  Richard T Robinson; Shabaana A Khader; Cynthia A Martino; Jeffrey J Fountain; Maria Teixeira-Coelho; John E Pearl; Stephen T Smiley; Gary M Winslow; David L Woodland; Michael J Walter; Jose R Conejo-Garcia; Ueli Gubler; Andrea M Cooper
Journal:  J Exp Med       Date:  2010-03-08       Impact factor: 14.307

10.  Host genetics in granuloma formation: human-like lung pathology in mice with reciprocal genetic susceptibility to M. tuberculosis and M. avium.

Authors:  Elena Kondratieva; Nadya Logunova; Konstantin Majorov; Mikhail Averbakh; Alexander Apt
Journal:  PLoS One       Date:  2010-05-06       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.